Replies to post #213912 on Biotech Values

[north40000]

What happened to DXCM/JNJ? I noticed yesterday, per Gottlieb, that 9 companies were pre-certified to participate in an FDA program for CGM ....JNJ was 1 of them as was FIT, DXCM was not. Thought that was strange in light of earlier PR that FIT and DXCM were partnered for a CGM watch device, Ionic, to be introduced in 1980. I did not check recently, but DXCM was in JNJ/Animas device for CGM + insulin release.

[biomaven0]

>>FreeStyle Libre continuous glucose-monitoring system

From their website:

40% of the time when the device indicated that user sensor glucose values were at or below 60 mg/dL, user glucose values were actually in the range of 81–160 mg/dL

[DewDiligence]

[ABT] competitor DXCM is -6%/AH on this news.

Make that -16%.

[DewDiligence]

ABT’s own PR on Freestyle Libre FDA approval:

https://finance.yahoo.com/news/no-more-routine-finger-sticks-214200494.html

The stock is +4% today (an uncommonly large daily move) to an all-time high.

[DewDiligence]

ABT—Guggenheim sees Freestyle Libre being a $1.4B product by 2020 (FWIW):

http://www.barrons.com/articles/abbott-labs-billion-dollar-product-1506678681